ReMonit Gout
Mastering app for uric acid
Project Manager
PhD fellow
Postdoc
ABOUT THE PROJECT
O gout is an inflammatory rheumatic disease characterized by recurrent, highly painful seizures. If you go with an elevated uric acid level in the blood over time, uric acid crystals are formed, which can lead to acute inflammatory reactions in the joints. There is good drug treatment to lower the uric acid level. If patients receive properly dosed drug treatment, they can avoid having seizures if they continue to take the medicine daily.
In today's course of treatment, all patients who will start with uric acidic drugs, a conversation with a nurse. The nurse informs about gout, drug treatment and dietary advice. The patient is then followed up with monthly blood sampling and telephone consultations with a nurse until the treatment target is reached.
In the Remonit Gout study, we will investigate whether the mastery app Urika can support patients starting uric acid treatment. The app was developed in collaboration with user representatives and clinicians, and has been thoroughly tested by 21 patients in a usefulness study.
The app contains information films and text about the disease and treatment methods, reminders for medication and blood tests, and a graph with an overview of the uric acid level and the treatment target of the patient. It also has a function for adapting medicine doses and a nurse messaging service.
A nurse will provide distance follow -up via a digital platform related to the app. We will test the digital follow-up in a clinical study (randomized, controlled, non-inferiority study), to investigate whether the follow-up is no worse than today's telephone follow-up with a nurse.
WHO CAN JOIN?
Participants in the study will be recruited among adult patients referred to the Diakonhjemmet Hospital, who are diagnosed with gout germination and will start with uric acid treatment.
It is also a requirement that the participants own a smartphone or tablet and have good Norwegian knowledge.
WHAT DOES THE STUDY INCLUDE?
The study lasts for 2 years. All patients receive a first consultation with a nurse at Diakonhjemmet Hospital. Patients who agree to participate in the study are randomly distributed (by drawing) to one of two groups:
- A group (the control group) should be followed up according to today's treatment course with monthly telephone consultations with a nurse.
- The other group (intervention group) will receive follow -up using the Self -Mastery app Urika and is followed up digitally by a nurse.
All participants should take blood tests and respond to a digital questionnaire at start -up, and after 1 and 2 years. In addition, everyone will be asked to answer a few questions every 3 months. Blood tests are taken each month until the treatment target is reached and 3 months after the goal is reached. Everyone who participates in the study will be called in for a blood test and consultation with a nurse in the hospital after 1 year, then patients will be followed up by their GP with blood tests approx. Every 6 months. After 2 years, participants will again be called in for blood tests and consultation with a nurse.
After 1 and 2 years, we will evaluate if digital follow-up is not inferior a nurse-led follow-up with telephone consultations in reaching the treatment target. We will also do a health economic evaluation of the two follow -up strategies.